Glyzerin Kinder Lambo (Glycerol)

Glyzerin Kinder Lambo is indicated for the temporary relief of constipation and fecal impaction in children when a gentle, locally acting laxative is desired.

• Mild constipation caused by diet low in fiber or fluid.
• Acute fecal impaction requiring softening of hardened stool.
• Preparation for bowel evacuation prior to diagnostic procedures.
• Short‑term use in children who have difficulty passing stool.
• Adjunct to dietary measures for promoting regular bowel movements.
• Constipation associated with limited physical activity or travel.
• Use in children with functional bowel disorders under caregiver supervision.

Glyzerin Kinder Lambo, like other glycerol‑based rectal solutions, can produce both local and systemic effects after administration. The majority of users experience only mild, short‑lasting symptoms that resolve without medical intervention. However, clinicians advise monitoring for less common but potentially serious reactions, especially in children with underlying health conditions. These effects are generally dose‑related and tend to diminish as the bowel habit normalizes.

Common

• Mild rectal irritation or burning.
• Loose stools or increased frequency.
• Minor abdominal cramping.
• Transient feeling of urgency to defecate.

Serious

• Severe rectal bleeding.
• Persistent abdominal pain.
• Allergic reaction (rash, swelling, or breathing difficulty).

When using Glyzerin Kinder Lambo, caregivers should follow safety guidelines to minimize risk and ensure appropriate use in children.

• Confirm the child is at least 2 years old before administration.
• Use only the supplied applicator or a clean, pediatric‑size syringe.
• Do not exceed the recommended single dose; repeat dosing should be spaced at least 24 hours apart.
• Avoid use in children with known hypersensitivity to glycerol or other rectal preparations.
• Seek medical advice if constipation persists for more than three days despite treatment.
• Keep the product out of reach of children to prevent accidental ingestion.

Glycerol rectal solutions have limited systemic absorption, yet certain medications or clinical conditions may modify their safety profile, requiring attention to possible interactions.

Avoid

• Concurrent use of strong stimulant laxatives (e.g., bisacodyl) that may cause excessive bowel activity.
• Co‑administration with oral osmotic agents (e.g., polyethylene glycol) without medical supervision.
• Use with rectal phosphate enemas, which may increase electrolyte disturbances.

Use with caution

• Anticholinergic drugs that can reduce intestinal motility, potentially decreasing glycerol efficacy.
• Medications that affect electrolyte balance, such as diuretics, may amplify fluid shifts.
• Children receiving intravenous fluids or electrolytes; monitor for potential shifts.
• Patients with renal impairment should be monitored for fluid overload.